{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:29:41Z","timestamp":1786987781031,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic and Interventional Imaging"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.diii.2022.10.013","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T20:50:05Z","timestamp":1668718205000},"page":"123-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Improving pain control during transarterial chemoembolization for hepatocellular carcinoma performed under local anesthesia with multimodal analgesia"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8024-3445","authenticated-orcid":false,"given":"Quentin","family":"Vanderbecq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Gr\u00e9gory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0352-4128","authenticated-orcid":false,"given":"Jeremy","family":"Dana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Dioguardi Burgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5000-4921","authenticated-orcid":false,"given":"Lorenzo","family":"Garzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Raynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Fr\u00e9my","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Paulatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3919-4135","authenticated-orcid":false,"given":"Mohamed","family":"Bouattour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0318-3853","authenticated-orcid":false,"given":"Juliette","family":"Kavafyan-Lasserre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Vilgrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7464-3939","authenticated-orcid":false,"given":"Maxime","family":"Ronot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diii.2022.10.013_bib0001","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.diii.2022.10.013_bib0002","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.diii.2022.10.013_bib0003","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.diii.2022.10.013_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004787.pub2","article-title":"Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma","author":"Oliveri","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.diii.2022.10.013_bib0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.diii.2022.01.006","article-title":"Local recurrence following complete radiologic response in patients treated with transarterial chemoembolization for hepatocellular carcinoma","volume":"103","author":"Young","year":"2022","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2022.10.013_bib0006","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.diii.2022.01.013","article-title":"A step toward a better understanding of hepatocellular progression after transarterial embolization","volume":"103","author":"Dohan","year":"2022","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2022.10.013_bib0007","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"European association for the study of the liver. EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.diii.2022.10.013_bib0008","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000514174","article-title":"Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 Update","volume":"10","author":"Kudo","year":"2021","journal-title":"Liver Cancer"},{"key":"10.1016\/j.diii.2022.10.013_bib0009","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12072-010-9165-7","article-title":"Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma","volume":"4","author":"Omata","year":"2010","journal-title":"Hepatol Int"},{"key":"10.1016\/j.diii.2022.10.013_bib0010","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.diii.2022.10.013_bib0011","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ctrv.2018.11.002","article-title":"Updated use of TACE for hepatocellular carcinoma treatment: how and when to use it based on clinical evidence","volume":"72","author":"Raoul","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.diii.2022.10.013_bib0012","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/liv.12818","article-title":"Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study","volume":"35","author":"Park","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.diii.2022.10.013_bib0013","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jvir.2014.02.025","article-title":"Safety and feasibility of same-day discharge of patients with hepatocellular carcinoma treated with transarterial chemoembolization with drug-eluting beads in a liver transplantation program","volume":"25","author":"Nasser","year":"2014","journal-title":"J Vasc Interv Rad"},{"key":"10.1016\/j.diii.2022.10.013_bib0014","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hep.28453","article-title":"Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data","volume":"64","author":"Lencioni","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.diii.2022.10.013_bib0015","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/NCC.0000000000000302","article-title":"Management of postembolization syndrome following hepatic transarterial chemoembolization for primary or metastatic liver cancer","volume":"39","author":"Blackburn","year":"2016","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.diii.2022.10.013_bib0016","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.3748\/wjg.v26.i30.4442","article-title":"Predictive model for acute abdominal pain after transarterial chemoembolization for liver cancer","volume":"26","author":"Bian","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.diii.2022.10.013_bib0017","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1148\/radiol.2018180257","article-title":"A Predictive model for postembolization syndrome after transarterial hepatic chemoembolization of hepatocellular carcinoma","volume":"290","author":"Khalaf","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2022.10.013_bib0018","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1007\/s00330-020-07404-5","article-title":"Predictive factors of severe abdominal pain during and after transarterial chemoembolization for hepatocellular carcinoma","volume":"31","author":"Pachev","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diii.2022.10.013_bib0019","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2147\/JPR.S246197","article-title":"Determination of risk factors for pain after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma","volume":"13","author":"Wang","year":"2020","journal-title":"J Pain Res"},{"key":"10.1016\/j.diii.2022.10.013_bib0020","first-page":"820","article-title":"Post embolization syndrome in doxorubicin eluting chemoembolization with DC bead","volume":"59","author":"Pomoni","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.diii.2022.10.013_bib0021","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00330-011-2118-2","article-title":"Transarterial chemoembolisation: effect of selectivity on tolerance, tumour response and survival","volume":"21","author":"Bouvier","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diii.2022.10.013_bib0022","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/bjc.2014.199","article-title":"Randomised controlled trial of doxorubicin-eluting beads vs. conventional chemoembolisation for hepatocellular carcinoma","volume":"111","author":"Golfieri","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.diii.2022.10.013_bib0023","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1051-0443(07)61911-3","article-title":"Determinants of postembolization syndrome after hepatic chemoembolization","volume":"12","author":"Leung","year":"2001","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.diii.2022.10.013_bib0024","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/S0140-6736(00)02162-0","article-title":"Adjunctive non-pharmacological analgesia for invasive medical procedures: a randomised trial","volume":"355","author":"Lang","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.diii.2022.10.013_bib0025","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/hep.29403","article-title":"A randomized placebo-controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization","volume":"67","author":"Ogasawara","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.diii.2022.10.013_bib0026","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jvir.2017.07.021","article-title":"Dexamethasone prophylaxis to alleviate postembolization syndrome after transarterial chemoembolization for hepatocellular carcinoma: a randomized, double-blinded, placebo-controlled study","volume":"28","author":"Yang","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.diii.2022.10.013_bib0027","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.diii.2020.04.005","article-title":"Interventional oncology at the time of COVID-19 pandemic: problems and solutions","volume":"101","author":"Denys","year":"2020","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2022.10.013_bib0028","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1440-1681.12506","article-title":"Nefopam analgesia and its role in multimodal analgesia: a review of preclinical and clinical studies","volume":"43","author":"Girard","year":"2016","journal-title":"Clin Exp Pharmacol P"},{"key":"10.1016\/j.diii.2022.10.013_bib0029","series-title":"WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents","year":"2018"},{"key":"10.1016\/j.diii.2022.10.013_bib0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/biomet\/64.2.191","article-title":"Group sequential methods in the design and analysis of clinical trials","volume":"64","author":"Pocock","year":"1977","journal-title":"Biometrika"},{"key":"10.1016\/j.diii.2022.10.013_bib0031","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1213\/01.ANE.0000142121.24052.25","article-title":"The median effective dose of tramadol and morphine for postoperative patients: a study of interactions","volume":"100","author":"Marcou","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.diii.2022.10.013_bib0032","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1097\/00000539-200212000-00045","article-title":"The addition of a tramadol infusion to morphine patient-controlled analgesia after abdominal surgery: a double-blinded, placebo-controlled randomized trial","volume":"95","author":"Webb","year":"2002","journal-title":"Anesth Analg"},{"key":"10.1016\/j.diii.2022.10.013_bib0033","first-page":"45","article-title":"The use of tramadol and morphine for pain relief after abdominal hysterectomy","volume":"32","author":"Kocabas","year":"2005","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.diii.2022.10.013_bib0034","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.phrs.2010.02.011","article-title":"Analysis of the opioid\u2013opioid combinations according to the nociceptive stimulus in mice","volume":"61","author":"Romero","year":"2010","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.diii.2022.10.013_bib0035","first-page":"31","article-title":"The analgesic interaction of tramadol and morphine in rats: an isobolographic study","volume":"10","author":"Savadkoohi","year":"2019","journal-title":"Vet Res Forum"},{"key":"10.1016\/j.diii.2022.10.013_bib0036","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1366-0071(00)80026-1","article-title":"Efficacy and safety of tramadol and morphine in patients with extremely severe postoperative pain","volume":"3","author":"Wiebalck","year":"2000","journal-title":"Acute Pain"},{"key":"10.1016\/j.diii.2022.10.013_bib0037","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1213\/01.ANE.0000180271.88987.5B","article-title":"The combination of tramadol and morphine may be recommended for postoperative analgesia","volume":"101","author":"Webb","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.diii.2022.10.013_bib0038","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/apt.15639","article-title":"Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of patients with compensated cirrhosis","volume":"51","author":"Moon","year":"2020","journal-title":"Aliment Pharm Therap"},{"key":"10.1016\/j.diii.2022.10.013_bib0039","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00270-017-1564-x","article-title":"Post-procedural care in interventional radiology: what every interventional radiologist should know-Part I: standard post-procedural instructions and follow-up care","volume":"40","author":"Taslakian","year":"2017","journal-title":"Cardiovasc Inter Rad"},{"key":"10.1016\/j.diii.2022.10.013_bib0040","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1097\/00000542-200512000-00025","article-title":"Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials","volume":"103","author":"Elia","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.diii.2022.10.013_bib0041","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3959(97)00005-5","article-title":"The visual analogue pain intensity scale: what is moderate pain in millimetres?","volume":"72","author":"Collins","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.diii.2022.10.013_bib0042","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s41747-021-00204-6","article-title":"Transarterial chemoembolisation in patients with hepatocellular carcinoma: low-dose doxorubicin reduces post-embolisation syndrome without affecting survival-prospective interventional study","volume":"5","author":"Bessar","year":"2021","journal-title":"Eur Radiol Exp"},{"key":"10.1016\/j.diii.2022.10.013_bib0043","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.3748\/wjg.v20.i12.3069","article-title":"Transarterial chemoembolization and bland embolization for hepatocellular carcinoma","volume":"20","author":"Tsochatzis","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.diii.2022.10.013_bib0044","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1472-8206.2007.00499.x","article-title":"French Network of pharmacovigilance centers. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database","volume":"21","author":"Durrieu","year":"2007","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.diii.2022.10.013_bib0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacr.2021.09.029","article-title":"Effect and safety of prophylactic parecoxib for pain control of transarterial chemoembolization in liver cancer: a single-center, parallel-group, randomized trial","volume":"19","author":"Lyu","year":"2022","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.diii.2022.10.013_bib0046","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1007\/s00330-016-4207-8","article-title":"Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial","volume":"26","author":"Lv","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diii.2022.10.013_bib0047","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00270-001-0073-z","article-title":"Intraarterial lidocaine administration for relief of pain resulting from transarterial chemoembolization of hepatocellular carcinoma: its effectiveness and optimal timing of administration","volume":"24","author":"Lee","year":"2001","journal-title":"Cardiovasc Inter Rad"},{"key":"10.1016\/j.diii.2022.10.013_bib0048","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jvir.2008.01.027","article-title":"Beneficial effects of hypnosis and adverse effects of empathic attention during percutaneous tumor treatment: when being nice does not suffice","volume":"19","author":"Lang","year":"2008","journal-title":"J Vasc Interv Rad"}],"container-title":["Diagnostic and Interventional Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211568422002182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211568422002182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:38:11Z","timestamp":1761932291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211568422002182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2211568422002182"],"URL":"https:\/\/doi.org\/10.1016\/j.diii.2022.10.013","relation":{},"ISSN":["2211-5684"],"issn-type":[{"value":"2211-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving pain control during transarterial chemoembolization for hepatocellular carcinoma performed under local anesthesia with multimodal analgesia","name":"articletitle","label":"Article Title"},{"value":"Diagnostic and Interventional Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diii.2022.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 fran\u00e7aise de radiologie. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}